                         SEQUENCE LISTING

<110>  WuXi Biologics (Shanghai) CO., LTD. 
       Wuxi Biologics Ireland Limited
 
<120>  FULLY HUMAN ANTIBODIES AGAINST OX40, METHOD FOR PREPARING THE SAME, AND USE THEREOF

<130>  IEC196014PCT

<150>  PCT/CN2018/121264
<151>  2018-12-14

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HCDR amino acid sequence

<400>  1

Gly Phe Thr Phe Ser Ser Leu Gly Met His 
1               5                   10  


<210>  2
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  LCDR amino acid sequence

<400>  2

Ser Gly Ser Ser Thr Asn Ile Gly Asn Asn Ala Val Asn 
1               5                   10              


<210>  3
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HCDR amino acid sequence

<400>  3

Val Ser Ser Tyr Asp Gln Ser Asn Lys Tyr Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  LCDR amino acid sequence

<400>  4

Tyr Asn Asp Leu Val Pro Ser 
1               5           


<210>  5
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HCDR amino acid sequence

<400>  5

Asp Leu Thr Gln Ser Lys Thr Trp Ser Arg Tyr Tyr Tyr Tyr Gly Met 
1               5                   10                  15      


Asp Val 
        


<210>  6
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  LCDR amino acid sequence

<400>  6

Ala Thr Trp Asp Asp Ser Leu Ser Gly Val Val 
1               5                   10      


<210>  7
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HCDR amino acid sequence

<400>  7

Val Thr Ser Tyr Asp Ser Ser Asn Lys Tyr Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  8
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Variable region amino acid sequence

<400>  8

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Leu 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ser Ser Tyr Asp Gln Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Leu Thr Gln Ser Lys Thr Trp Ser Arg Tyr Tyr Tyr Tyr 
            100                 105                 110         


Gly Met Asp Val Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  9
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Variable region amino acid sequence

<400>  9

Gln Ser Val Val Thr Gln Pro Pro Ser Val Ser Glu Ala Pro Arg Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Thr Asn Ile Gly Asn Asn 
            20                  25                  30          


Ala Val Asn Trp Tyr Gln Gln Leu Pro Gly Glu Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Tyr Asn Asp Leu Val Pro Ser Gly Val Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Trp Asp Asp Ser Leu 
                85                  90                  95      


Ser Gly Val Val Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  10
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Variable region amino acid sequence

<400>  10

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Leu 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Thr Ser Tyr Asp Ser Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Leu Thr Gln Ser Lys Thr Trp Ser Arg Tyr Tyr Tyr Tyr 
            100                 105                 110         


Gly Met Asp Val Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  11
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Variable region nucleotide sequence

<400>  11
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agcttaggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt tcctcatatg atcagagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaagatctc      300

actcaaagca aaacatggtc tcgatactac tactacggta tggacgtctg gggccaaggg      360

accctggtca ccgtctcgag t                                                381


<210>  12
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Variable region nucleotide sequence

<400>  12
cagtctgtcg tgacgcagcc gccctcggtg tctgaagccc ccaggcagag ggtcaccatc       60

tcctgttctg gaagcagcac caacatcgga aataatgctg taaactggta ccagcaactc      120

ccaggagagg ctcccaaact cctcatctat tataatgatc tagtgccctc aggggtctct      180

gaccgattct ctggctccaa gtctggcacc tctgcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgca acatgggatg acagcctgtc gggtgtggtt      300

ttcggcggag gcaccaaggt gaccgtcctc                                       330


<210>  13
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Variable region nucleotide sequence

<400>  13
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agcttaggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt acctcatatg attcaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaagatctc      300

actcaaagca aaacatggtc tcgatactac tactacggta tggacgtctg gggccaaggg      360

accctggtca ccgtctcgag t                                                381


